These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30632994)

  • 1. Influence of aversive stimulation on haloperidol-induced catalepsy in rats.
    Barroca NCB; Guarda MD; da Silva NT; Colombo AC; Reimer AE; Brandão ML; de Oliveira AR
    Behav Pharmacol; 2019 Apr; 30(2 and 3-Spec Issue):229-238. PubMed ID: 30632994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic mechanisms underlying catalepsy, fear and anxiety: do they interact?
    Colombo AC; de Oliveira AR; Reimer AE; Brandão ML
    Behav Brain Res; 2013 Nov; 257():201-7. PubMed ID: 24120401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct effects of haloperidol in the mediation of conditioned fear in the mesolimbic system and processing of unconditioned aversive information in the inferior colliculus.
    Muthuraju S; Nobre MJ; Saito VM; Brandao ML
    Neuroscience; 2014 Mar; 261():195-206. PubMed ID: 24384225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Immediate Aversive Stimulation on Haloperidol-Induced Catalepsy in Rats.
    Waku I; Reimer AE; de Oliveira AR
    Front Behav Neurosci; 2022; 16():867180. PubMed ID: 35481243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced expression of haloperidol conditioned catalepsy in rats by the dopamine D3 receptor antagonists nafadotride and NGB 2904.
    Banasikowski TJ; Beninger RJ
    Eur Neuropsychopharmacol; 2012 Oct; 22(10):761-8. PubMed ID: 22410316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-trial dopaminergic modulation of conditioned catalepsy: A single apomorphine induced increase/decrease in dopaminergic activation immediately following a conditioned catalepsy response can reverse/enhance a haloperidol conditioned and sensitized catalepsy response.
    Oliveira LR; Dias FRC; Santos BG; Silva JLL; Carey RJ; Carrera MP
    Behav Brain Res; 2016 Sep; 311():87-98. PubMed ID: 27173428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenosine A2 receptors modulate haloperidol-induced catalepsy in rats.
    Mandhane SN; Chopde CT; Ghosh AK
    Eur J Pharmacol; 1997 Jun; 328(2-3):135-41. PubMed ID: 9218695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haloperidol conditioned catalepsy in rats: a possible role for D1-like receptors.
    Banasikowski TJ; Beninger RJ
    Int J Neuropsychopharmacol; 2012 Nov; 15(10):1525-34. PubMed ID: 22093169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haloperidol and methylphenidate alter motor behavior and responses to conditioned fear of Carioca Low-conditioned Freezing rats.
    Lages YV; Maisonnette SS; Rosseti FP; Galvão BO; Landeira-Fernandez J
    Pharmacol Biochem Behav; 2021 Dec; 211():173296. PubMed ID: 34752797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. State-dependent blockade of haloperidol-induced sensitization of catalepsy by MK-801.
    Schmidt WJ; Tzschentke TM; Kretschmer BD
    Eur J Neurosci; 1999 Sep; 11(9):3365-8. PubMed ID: 10510204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CB1 cannabinoid receptor-mediated anandamide signaling mechanisms of the inferior colliculus modulate the haloperidol-induced catalepsy.
    Medeiros P; de Freitas RL; Silva MO; Coimbra NC; Melo-Thomas L
    Neuroscience; 2016 Nov; 337():17-26. PubMed ID: 27595886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The interaction of a state of haloperidol-induced catalepsy and a passive-avoidance conditioned reflex].
    Bazian AS; Getsova VN; Orlova NV
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1996; 46(4):787-94. PubMed ID: 8984818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haloperidol catalepsy consolidation in the rat as a model of neuromodulatory integration.
    Bazyan AS; Getsova VM; Orlova NV
    Neuroscience; 2000; 99(2):279-88. PubMed ID: 10938433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a dopamine D1/5 receptor antagonist on haloperidol-induced inhibition of the acquisition of conditioned fear.
    Inoue T; Izumi T; Li XB; Kitaichi Y; Nakagawa S; Koyama T
    Eur J Pharmacol; 2005 Sep; 519(3):253-8. PubMed ID: 16135362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosomatostatin- and haloperidol-induced catalepsy in Wistar rats: Differential responsiveness to sleep deprivation.
    Ionov ID; Pushinskaya II; Gorev NP; Frenkel DD
    Neurosci Lett; 2018 Sep; 684():72-77. PubMed ID: 29990558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated testing of rats markedly enhances the duration of effects induced by haloperidol on treadmill locomotion, catalepsy, and a conditioned avoidance response.
    Hillegaart V; Ahlenius S; Magnusson O; Fowler CJ
    Pharmacol Biochem Behav; 1987 May; 27(1):159-64. PubMed ID: 3615537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of haloperidol-induced catalepsy in rats by GABAergic neural substrate in the inferior colliculus.
    Tostes JG; Medeiros P; Melo-Thomas L
    Neuroscience; 2013; 255():212-8. PubMed ID: 24125891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conditioned increase of locomotor activity induced by haloperidol.
    De la Casa LG; Cárcel L; Ruiz-Salas JC; Vicente L; Mena A
    PLoS One; 2018; 13(10):e0200178. PubMed ID: 30281607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention by (+/-)-8-hydroxy-2-(di-n-propylamino)tetralin of both catalepsy and the rises in rat striatal dopamine metabolism caused by haloperidol.
    Andersen HL; Kilpatrick IC
    Br J Pharmacol; 1996 May; 118(2):421-7. PubMed ID: 8735647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conditioned catalepsy vs. Increase in locomotor activity induced by haloperidol.
    De la Casa LG; Cintado MA; González-Tirado G; Cárcel L
    Neurosci Lett; 2023 Apr; 802():137174. PubMed ID: 36906082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.